from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2572c/aspS

LFCtreatmentdescriptionclass of inhibitor

0.296

Amikacinug/mL Amikacintranslation

-0.639

Cap5-10ug/mL Capreomycintranslation

-1.224

Rox10-50 ug/mL Roxithromycintranslation

1.033

SM2-5 ug/mL Streptomycintranslation

-0.644

Tet5-10 ug/mL Tetracyclinetranslation

1.189

Rif0.2-5ug/mL Rifampicintranscription

-0.837

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.293

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.353

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.182

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.832

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.349

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-4.011

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.987

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.553

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.426

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.216

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.096

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.253

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.381

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-2.493

KCN5-20 ug/mL Potassium cyaniderespiration

-0.097

NaN30.2-2 mM Sodium aziderespiration

-0.327

Nigericin50 uM Nigericinrespiration

0.516

TRC10-150 ug/mL Triclosanrespiration

-0.740

TRZ10-25 ug/mL Thioridazinerespiration

-1.989

Valinomycin0.5-10 uM Valinomycinrespiration

0.228

ZnSO42 mM ZnSO4respiration

0.747

menadione6-10 ug/mL Menadionerespiration

0.205

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.072

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.349

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.447

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.101

NRP_1Non-replicating persistence stage 1dosRassociated

0.277

Amp0.2mg/mL AmpicillincellWall

-0.228

Cephalexin20-100 ug/mL CephalexincellWall

-0.078

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.393

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.239

EMB10-20 ug/mL EthambutolcellWall

0.707

Eta12-40 ug/mL EthionamidecellWall

1.261

INH0.2-0.4 ug/mL IsoniazidcellWall

0.480

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.893

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.935

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.615

BZA0.12 mg/mL BenzamidearomaticAmides

0.696

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.706

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

1.118

H2O24 mM hydrogen peroxideDNAdamaging

-0.194

Levo10 ug/mL LevofloxacinDNAdamaging

0.589

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.848

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.212

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.053

UVUV-irradiationDNAdamaging

0.208

ARP41-4 ug/mL Antitubercular compound ARP4?

0.055

Antimycin12.5-50 ug/mL Antimycin A?

-0.629

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.870

PA_110-50 ug/mL Antitubercular compound PA-1?

0.487

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.556

PA8240.2-2 ug/mL PA-824?

-0.640

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.008

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.831

Verapamil50 uM Verapamil?

-0.631

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.807

methoxatin10-20 ug/mL Methoxatin?